Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1622 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Merck, Glenmark Settle Zetia Patent Dispute

The settlement effectively ends the lawsuit involving a challenge by Glenmark which sought to launch a generic version of Zetia before the April 2017 expiration of the patent